Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin Inactivated Poliovirus Vaccine in Infants
NCT03526978Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started Aug 2017; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03526978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03526978.